Abstract: FN3 domains that specifically bind to CD137, their conjugates, isolated nucleotides encoding the molecules, vectors, host cells, and methods of making and using them are useful in therapeutic and diagnostic applications.
Type:
Grant
Filed:
December 13, 2017
Date of Patent:
April 7, 2020
Assignee:
HANSSEN BIOTECH, INC
Inventors:
Michael Diem, Rebecca Hawkins, Steven Jacobs, Manuel Sepulveda